166 related articles for article (PubMed ID: 11059508)
1. Role of herbal compounds (PC-SPES) in hormone-refractory prostate cancer: two case reports.
de la Taille A; Hayek OR; Burchardt M; Burchardt T; Katz AE
J Altern Complement Med; 2000 Oct; 6(5):449-51. PubMed ID: 11059508
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of action of herbal supplement PC-SPES: elucidation of effects of individual herbs of PC-SPES on proliferation and prostate specific gene expression in androgen-dependent LNCaP cells.
Hsieh TC; Wu JM
Int J Oncol; 2002 Mar; 20(3):583-8. PubMed ID: 11836572
[TBL] [Abstract][Full Text] [Related]
3. Prospective trial of the herbal supplement PC-SPES in patients with progressive prostate cancer.
Small EJ; Frohlich MW; Bok R; Shinohara K; Grossfeld G; Rozenblat Z; Kelly WK; Corry M; Reese DM
J Clin Oncol; 2000 Nov; 18(21):3595-603. PubMed ID: 11054432
[TBL] [Abstract][Full Text] [Related]
4. PC-SPES: a herbal therapy for the treatment of hormone refractory prostate cancer.
Meyer JP; Gillatt DA
Prostate Cancer Prostatic Dis; 2002; 5(1):13-5. PubMed ID: 15195124
[TBL] [Abstract][Full Text] [Related]
5. PC-SPES and prostate cancer.
Oh WK; Small EJ
Urol Clin North Am; 2002 Feb; 29(1):59-66, viii. PubMed ID: 12109356
[TBL] [Abstract][Full Text] [Related]
6. Effects of a phytotherapeutic agent, PC-SPES, on prostate cancer: a preliminary investigation on human cell lines and patients.
de la Taille A; Hayek OR; Buttyan R; Bagiella E; Burchardt M; Katz AE
BJU Int; 1999 Nov; 84(7):845-50. PubMed ID: 10532984
[TBL] [Abstract][Full Text] [Related]
7. Gene profiling and promoter reporter assays: novel tools for comparing the biological effects of botanical extracts on human prostate cancer cells and understanding their mechanisms of action.
Bigler D; Gulding KM; Dann R; Sheabar FZ; Conaway MR; Theodorescu D
Oncogene; 2003 Feb; 22(8):1261-72. PubMed ID: 12606954
[TBL] [Abstract][Full Text] [Related]
8. UsToo PC-SPES surveys: review of studies and update of previous survey results.
Porterfield H
Mol Urol; 2000; 4(3):289-91;discussion 293. PubMed ID: 11062386
[TBL] [Abstract][Full Text] [Related]
9. Clinical and biologic activity of an estrogenic herbal combination (PC-SPES) in prostate cancer.
DiPaola RS; Zhang H; Lambert GH; Meeker R; Licitra E; Rafi MM; Zhu BT; Spaulding H; Goodin S; Toledano MB; Hait WN; Gallo MA
N Engl J Med; 1998 Sep; 339(12):785-91. PubMed ID: 9738085
[TBL] [Abstract][Full Text] [Related]
10. Activity of the herbal combination, PC-SPES, in the treatment of patients with androgen-independent prostate cancer.
Oh WK; George DJ; Hackmann K; Manola J; Kantoff PW
Urology; 2001 Jan; 57(1):122-6. PubMed ID: 11164156
[TBL] [Abstract][Full Text] [Related]
11. Herbal supplement PC-Spes for prostate cancer.
de Lemos ML
Ann Pharmacother; 2002 May; 36(5):921-6. PubMed ID: 11978173
[TBL] [Abstract][Full Text] [Related]
12. Prevention and management of prostate cancer using PC-SPES: a scientific perspective.
Hsieh TC; Lu X; Chea J; Wu JM
J Nutr; 2002 Nov; 132(11 Suppl):3513S-3517S. PubMed ID: 12421879
[TBL] [Abstract][Full Text] [Related]
13. PC-SPES, a dietary supplement for the treatment of hormone-refractory prostate cancer.
Pfeifer BL; Pirani JF; Hamann SR; Klippel KF
BJU Int; 2000 Mar; 85(4):481-5. PubMed ID: 10691828
[TBL] [Abstract][Full Text] [Related]
14. Herbal therapy PC-SPES: in vitro effects and evaluation of its efficacy in 69 patients with prostate cancer.
de la Taille A; Buttyan R; Hayek O; Bagiella E; Shabsigh A; Burchardt M; Burchardt T; Chopin DK; Katz AE
J Urol; 2000 Oct; 164(4):1229-34. PubMed ID: 10992371
[TBL] [Abstract][Full Text] [Related]
15. Prospective, multicenter, randomized phase II trial of the herbal supplement, PC-SPES, and diethylstilbestrol in patients with androgen-independent prostate cancer.
Oh WK; Kantoff PW; Weinberg V; Jones G; Rini BI; Derynck MK; Bok R; Smith MR; Bubley GJ; Rosen RT; DiPaola RS; Small EJ
J Clin Oncol; 2004 Sep; 22(18):3705-12. PubMed ID: 15289492
[TBL] [Abstract][Full Text] [Related]
16. Anti-tumor effects of PC-SPES, an herbal formulation in prostate cancer.
Tiwari RK; Geliebter J; Garikapaty VP; Yedavelli SP; Chen S; Mittelman A
Int J Oncol; 1999 Apr; 14(4):713-9. PubMed ID: 10087319
[TBL] [Abstract][Full Text] [Related]
17. Rapid rise of serum prostate specific antigen levels after discontinuation of the herbal therapy PC-SPES in patients with advanced prostate carcinoma: report of four cases.
Oh WK; George DJ; Kantoff PW
Cancer; 2002 Feb; 94(3):686-9. PubMed ID: 11857300
[TBL] [Abstract][Full Text] [Related]
18. Disseminated intravascular coagulation and PC-SPES: a case report and literature review.
Lock M; Loblaw DA; Choo R; Imrie K
Can J Urol; 2001 Aug; 8(4):1326-9. PubMed ID: 11564276
[TBL] [Abstract][Full Text] [Related]
19. The effects of phytotherapeutic agents on prostate cancer: an overview of recent clinical trials of PC SPES.
Pirani JF
Urology; 2001 Aug; 58(2 Suppl 1):36-8. PubMed ID: 11502444
[TBL] [Abstract][Full Text] [Related]
20. Herbal composition PC-SPES for management of prostate cancer: identification of active principles.
Sovak M; Seligson AL; Konas M; Hajduch M; Dolezal M; Machala M; Nagourney R
J Natl Cancer Inst; 2002 Sep; 94(17):1275-81. PubMed ID: 12208892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
